文献速递妇科肿瘤

HPV DNA恒温扩增检测用于宫颈癌筛查的评价

[Application of isothermal HPV DNA amplification test in cervical cancer screening].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2018-01-01

研究纳入内蒙古2 774名30~64岁健康妇女,比较Isomega与cobas4800检测HPV DNA的一致性,并以病理诊断为金标准评价CIN2+检出效能。两种方法高危HPV总一致率为94.84%(Kappa=0.82),Isomega检出CIN2+的敏感度和特异度分别为87.76%和82.94%。结论认为两法一致性较好,可用于宫颈癌筛查。

要点

  • Isomega与cobas4800高危HPV总一致率94.84%(Kappa=0.82)
  • Isomega检出CIN2+敏感度87.76%、特异度82.94%
  • 两法检测HPV16/18分型准确性高,可用于人群筛查

核心结论

  • Isomega与cobas4800一致性较好,检测HPV16和18型准确性高,具有较高敏感度和特异度,可用于临床检测和大规模宫颈癌筛查。

研究设计与样本

  • 2016年6月至8月招募内蒙古2 774名30~64岁健康妇女进行宫颈癌筛查。
  • 采用Isomega和cobas4800检测HPV DNA,结果不一致标本用INNO-LiPA线性探针法分型校正。
  • 以病理诊断为金标准,评价两法检出CIN2及以上病变的有效性和准确性。

主要发现

  • Isomega与cobas4800高危HPV总一致率94.84%(Kappa=0.82)。
  • HPV16、HPV18和其他高危型一致率分别为99.68%(Kappa=0.95)、99.78%(Kappa=0.91)和94.34%(Kappa=0.76)。
  • Isomega与INNO-LiPA参考方法对HPV16、18和其他高危型一致率分别为99.71%(Kappa=0.96)、99.86%(Kappa=0.94)和96.76%(Kappa=0.87)。
  • cobas4800与参考方法对HPV16、18和其他高危型一致率分别为99.82%(Kappa=0.97)、99.86%(Kappa=0.94)和97.51%(Kappa=0.90)。
  • Isomega检出CIN2+(含CIN2、CIN3和鳞癌)敏感度87.76%、特异度82.94%;cobas4800分别为89.80%和85.06%。

关键数值与推荐

  • Isomega检出CIN2+敏感度87.76%、特异度82.94%;cobas4800为89.80%和85.06%。
  • Isomega与cobas4800高危HPV总一致率94.84%(Kappa=0.82)。

临床怎么用

  • 可将Isomega作为宫颈癌初筛的HPV DNA检测方法之一,用于人群筛查和临床检测。
  • 对HPV16/18分型结果可较可靠地用于风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To evaluate the feasibility and effectiveness of isothermal human papillomavirus (HPV) DNA amplification test as a primary screening test in the early detection of cervical cancer. Methods: From June to August 2016, 2, 774 women aged 30-64 years old from Inner Mongolia were recruited for cervical cancer screening. HPV DNA was detected by Isomega and cobas4800. INNO-LiPA HPV Genotyping Extra was served as a reference method for the cases whose results were inconsistent by using these two methods. Histological diagnosis was considered as a gold standard to estimate the effectiveness and accuracy of Isomega and cobas4800 for detecting CIN2 or greater. Results: The concordance of Isomega and cobas4800 was 94.84% (Kappa=0.82) for high risk HPV (HR-HPV), 99.68% (Kappa=0.95) for HPV16, 99.78% (Kappa=0.91) for HPV18 and 94.34% (Kappa=0.76) for other HR-HPV types. The concordances of Isomega and the reference were 99.71% (Kappa=0.96), 99.86% (Kappa=0.94) and 96.76% (Kappa=0.87) for HPV16, 18 and other HR-HPV, respectively, while the concordances of cobas4800 and the reference were 99.82% (Kappa=0.97), 99.86% (Kappa=0.94) and 97.51% (Kappa=0.90), respectively. The sensitivity and specificity of Isomega for detecting CIN2+ (including CIN2, CIN3 and squamous cell carcinoma) were 87.76% and 82.94%, respectively, while those of cobas4800 were 89.80% and 85.06%, respectively. Conclusions: The concordances of Isomega and cobas4800 is confident. These two methods can accurately detect the HPV16 and 18 genotyping, and have good sensitivity and specificity for clinical diagnosis and population screening of cervical cancer. 目的: 评价人乳头状瘤病毒(HPV)DNA恒温扩增检测技术Isomega应用在高危型别HPV DNA检测及宫颈病变诊断中的可行性及有效性。 方法: 招募2 774名30~64岁来自内蒙古自治区健康妇女进行宫颈癌筛查。采用Isomega和cobas4800 HPV检测技术进行HPV DNA检测,应用线性探针法(INNO-LiPA)对两种检测方法结果不一致的标本进行分型检测。以病理诊断为金标准,评价Isomega和cobas4800方法检出宫颈上皮内瘤变(CIN)2级及以上病变的有效性和准确性。 结果: Isomega与cobas4800检出HPV DNA的总一致率为94.84%(Kappa=0.82),检出HPV16、HPV18型和其他型别HR-HPV的一致率分别为99.68%(Kappa=0.95)、99.78%(Kappa=0.91)和94.34%(Kappa=0.76)。与INNO-LiPA校正结果比较,Isomega检出HPV16、HPV18和其他型别HR-HPV的一致率分别为99.71%(Kappa=0.96)、99.86%(Kappa=0.94)和96.76%(Kappa=0.87);cobas4800的一致率分别为99.82%(Kappa=0.97)、99.86%(Kappa=0.94)和97.51%(Kappa=0.90)。Isomega检出CIN2+(包括CIN2、CIN3和鳞癌)的敏感度和特异度分别为87.76%和82.94%,cobas4800分别为89.80%和85.06%。 结论: Isomega与cobas4800 HPV检测方法的一致性较好,检测HPV16和18型的准确性高,具有较高的敏感度和特异度,可用于临床检测和大规模人群的宫颈癌筛查。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Wang L, Jiang MY, Qin Y, et al. [Application of isothermal HPV DNA amplification test in cervical cancer screening]. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 29730922. doi:10.3760/cma.j.issn.0253-3766.2018.04.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。